Eikon Therapeutics ($EIKN) Insider Trading & Smart Money Activity

Eikon Therapeutics, Inc. · Biotechnology · Latest filing May 15, 2026

Eikon Therapeutics, Inc. ($EIKN) has 2 13F position changes on file.

Insider buyers (12 mo): 0
Insider sellers (12 mo): 0
Net insider $ (12 mo): $0
Congress trades (12 mo): 0
13F moves on file: 2
Analyst ratings on file: 0

EIKN insider buying and selling by quarter

Quarter	Congress buys / sales	13F added / cut
Q1 2026	0 / 0	0 / 0
Q2 2026	0 / 0	2 / 0
Q3 2026	0 / 0	0 / 0
Q4 2026	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All EIKN insider, congress, 13F and analyst activity

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	6M	Filing	Story
May 15, 2026	13F	Baker Bros. Advisors	New	+555.55K sh	$7.25M		-17.7%	-29.6%			Read
May 15, 2026	13F	Baker Bros. Advisors	New	+555.55K sh	$4.74M		-17.7%	-29.6%			—

1W / 1M / 6M = how EIKN moved from the trade or filing date.

Institutions moving EIKN (13F)

Baker Bros. Advisors2

Frequently asked questions

Which institutions changed their EIKN positions?

Recent 13F filers moving the stock include Baker Bros. Advisors.

Other biotechnology stocks

All stocks Insider cluster buys Top insider purchases Congress 13F institutions

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text